PAHC
Price
$39.81
Change
+$0.56 (+1.43%)
Updated
Oct 22 closing price
Capitalization
1.62B
13 days until earnings call
Intraday BUY SELL Signals
VTRS
Price
$18.48
Change
+$0.03 (+0.16%)
Updated
Oct 22 closing price
Capitalization
21.23B
14 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PAHC vs VTRS

PAHC vs VTRS Comparison Chart in %
View a ticker or compare two or three
VS
PAHC vs. VTRS commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAHC is a StrongBuy and VTRS is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for PAHC with price predictions
Oct 22, 2026

Momentum Indicator for PAHC turns positive, indicating new upward trend

PAHC saw its Momentum Indicator move above the 0 level on September 29, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 85 similar instances where the indicator turned positive. In 65 of the 85 cases, the stock moved higher in the following days. The odds of a move higher are at 76%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for PAHC just turned positive on October 01, 2026. Looking at past instances where PAHC's MACD turned positive, the stock continued to rise in 34 of 45 cases over the following month. The odds of a continued upward trend are 76%.

PAHC moved above its 50-day moving average on September 30, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for PAHC crossed bullishly above the 50-day moving average on October 07, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.

Following a +2.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where PAHC advanced for three days, in 214 of 285 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

The Aroon Indicator entered an Uptrend today. In 171 of 247 cases where PAHC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 69%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PAHC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.

PAHC broke above its upper Bollinger Band on October 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 34 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. PAHC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 51 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.193) is normal, around the industry mean (10.407). P/E Ratio (16.183) is within average values for comparable stocks, (-6.173). Projected Growth (PEG Ratio) (0.350) is also within normal values, averaging (2.152). Dividend Yield (0.012) settles around the average of (0.037) among similar stocks. P/S Ratio (0.953) is also within normal values, averaging (178.797).

The Tickeron Profit vs. Risk Rating rating for this company is 60 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is 90 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
a Summary for VTRS with price predictions
Oct 22, 2026

VTRS in +6.97% Uptrend, rising for three consecutive days on October 16, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where VTRS advanced for three days, in 223 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on VTRS as a result. In 53 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.

The Moving Average Convergence Divergence (MACD) for VTRS just turned positive on October 16, 2026. Looking at past instances where VTRS's MACD turned positive, the stock continued to rise in 34 of 48 cases over the following month. The odds of a continued upward trend are 71%.

The 10-day moving average for VTRS crossed bullishly above the 50-day moving average on September 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.

The Aroon Indicator entered an Uptrend today. In 195 of 280 cases where VTRS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 70%.

Bearish Trend Analysis

The 10-day RSI Indicator for VTRS moved out of overbought territory on October 19, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In 19 of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at 59%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VTRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.

VTRS broke above its upper Bollinger Band on October 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 7 (best 1 - 100 worst), indicating outstanding price growth. VTRS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.488) is normal, around the industry mean (10.407). P/E Ratio (-49.946) is within average values for comparable stocks, (-6.173). Projected Growth (PEG Ratio) (3.322) is also within normal values, averaging (2.152). Dividend Yield (0.026) settles around the average of (0.037) among similar stocks. P/S Ratio (1.347) is also within normal values, averaging (178.797).

The Tickeron Profit vs. Risk Rating rating for this company is 35 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is 53 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

FUNDAMENTALS RATINGS
PAHC vs VTRS: Fundamental Ratings
PAHC
VTRS
OUTLOOK RATING
1..100
4090
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
16
Undervalued
PROFIT vs RISK RATING
1..100
6035
SMR RATING
1..100
3491
PRICE GROWTH RATING
1..100
477
P/E GROWTH RATING
1..100
9053
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTRS's Valuation (16) in the null industry is somewhat better than the same rating for PAHC (51) in the Pharmaceuticals Major industry. This means that VTRS’s stock grew somewhat faster than PAHC’s over the last 12 months.

VTRS's Profit vs Risk Rating (35) in the null industry is in the same range as PAHC (60) in the Pharmaceuticals Major industry. This means that VTRS’s stock grew similarly to PAHC’s over the last 12 months.

PAHC's SMR Rating (34) in the Pharmaceuticals Major industry is somewhat better than the same rating for VTRS (91) in the null industry. This means that PAHC’s stock grew somewhat faster than VTRS’s over the last 12 months.

VTRS's Price Growth Rating (7) in the null industry is somewhat better than the same rating for PAHC (47) in the Pharmaceuticals Major industry. This means that VTRS’s stock grew somewhat faster than PAHC’s over the last 12 months.

VTRS's P/E Growth Rating (53) in the null industry is somewhat better than the same rating for PAHC (90) in the Pharmaceuticals Major industry. This means that VTRS’s stock grew somewhat faster than PAHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PAHCVTRS
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
59%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
44%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
67%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
68%
Advances
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 7 days ago
74%
Declines
ODDS (%)
Bearish Trend 10 days ago
74%
Bearish Trend 10 days ago
64%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
55%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
70%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (PAHC: $39.25 vs. VTRS: $18.45)
Brand notoriety: PAHC and VTRS are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: PAHC: 68% vs. VTRS: 101%
Market capitalization -- PAHC: $1.62B vs. VTRS: $21.23B
PAHC [@Pharmaceuticals: Generic] is valued at $1.62B. VTRS’s [@Pharmaceuticals: Generic] market capitalization is $21.23B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PAHC’s FA Score shows that 0 FA rating(s) are green while VTRS’s FA Score has 2 green FA rating(s).

  • PAHC’s FA Score: 0 green, 5 red.
  • VTRS’s FA Score: 2 green, 3 red.
According to our system of comparison, VTRS is a better buy in the long-term than PAHC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PAHC’s TA Score shows that 5 TA indicator(s) are bullish while VTRS’s TA Score has 6 bullish TA indicator(s).

  • PAHC’s TA Score: 5 bullish, 4 bearish.
  • VTRS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VTRS is a better buy in the short-term than PAHC.

Price Growth

PAHC (@Pharmaceuticals: Generic) experienced а +3.48% price change this week, while VTRS (@Pharmaceuticals: Generic) price change was +5.79% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -2.94%. For the same industry, the average monthly price growth was -9.84%, and the average quarterly price growth was +9.53%.

Reported Earning Dates

PAHC is expected to report earnings on Nov 04, 2026.

VTRS is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-2.94% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
PAHC
Daily Signal:
Gain/Loss:
VTRS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

PAHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, PAHC has been loosely correlated with ZTS. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if PAHC jumps, then ZTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAHC
1D Price
Change %
PAHC100%
+1.43%
ZTS - PAHC
61%
Loosely correlated
+2.99%
ELAN - PAHC
47%
Loosely correlated
+0.62%
VTRS - PAHC
29%
Poorly correlated
+0.16%
LFCR - PAHC
27%
Poorly correlated
N/A
AKBA - PAHC
26%
Poorly correlated
-3.95%
More

VTRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with AMRX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
+0.16%
AMRX - VTRS
42%
Loosely correlated
+1.39%
COLL - VTRS
36%
Loosely correlated
+2.55%
AMPH - VTRS
35%
Loosely correlated
-0.61%
ELAN - VTRS
34%
Loosely correlated
+0.62%
TEVA - VTRS
33%
Poorly correlated
-1.01%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HCA467.317.91
+1.72%
HCA Healthcare
MCY106.711.61
+1.53%
Mercury General Corp
LBRX39.420.19
+0.48%
LB Pharmaceuticals Inc
BCHT1.14N/A
N/A
Birchtech Corp
AUDC11.20-0.15
-1.32%
AudioCodes Ltd